Philip C Caron MD
Assistant Professor, Medicine, Weill Cornell Medical College
Request Appointment
500 Westchester AvenueWest Harrison, NY 10604
Fax+1 646-227-7283
Overview of Dr. Caron
Dr. Philip Caron is an oncologist in West Harrison, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Phelps Memorial Hospital Center. He received his medical degree from New York Medical College and has been in practice 31 years. He is one of 525 doctors at Memorial Sloan Kettering Cancer Center and one of 21 doctors at Phelps Memorial Hospital Center who specialize in Oncology. He has more than 40 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1986 - 1989
New York Medical CollegeClass of 1986
Columbia UniversityPhD, Pathobiology, 1978 - 1984
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 1987 - 2028
NJ State Medical License 2019 - 2027
CT State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Westchester Magazine: Top Doctors Castle Connolly
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
Publications & Presentations
PubMed
- Two decades of single-institution data reveal rare longterm survivors of relapsed/refractory Burkitt lymphoma.Rabeya Molla, Kurt Bantilan, Ellin Berman, Philip Caron, Lorenzo Falchi
Haematologica. 2026-01-01 - 2 citationsOutcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.Efrat Luttwak, Edith Tama Robin, Esther Drill, Alexander Boardman, Philip Caron
Leukemia & Lymphoma. 2025-07-01 - 7 citationsPhase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2025-03-10
Abstracts/Posters
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...Philip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaPhilip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaPhilip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Grant Support
- Targeted Sequential Therapy For CMLNational Cancer Institute1997–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
